The increase in striatal dopamine resulting from the combination of SOD1, Parkin and DJ-1 deficiency might represent early-stage nigrostriatal dysfunction and these mice may be useful for efforts to develop neuroprotective therapies targeting early stage abnormalities in PD pathogenesis. The gene discussed is PRKN; the disease is Parkinson disease.